FY2025 · ended Dec 31, 2025 · Revenue $1.04B, +8.8% YoY · Filed Feb 20, 2026
Balchem Corporation (BCPC) files with the SEC under industry code 2800, Chemicals & Allied Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.0 billion and net income of $154.8 million. As of Sep 30, 2026 it held $66.3 million in cash and investments and $18.4 million in total debt.
Revenue (TTM)
$1.11B
+9.4% vs year-ago TTM
Net income (TTM)
$170.85M
+14.5% vs year-ago TTM
Operating cash flow (TTM)
$223.82M
+11.0% vs year-ago TTM
Free cash flow
$89.45M
-28.1% vs prior year
EPS (TTM)
$5.30
+16.3% vs year-ago TTM
Dividend per share
$0.96
+10.3% vs prior year
Shares outstanding
32.03M
-1.6% vs prior year
Net cash
$47.82M
as of Sep 30, 2026
Operating margin
20.7%
FY 2026
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- BCPC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MD
- Headquarters
- Montvale, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 9326
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- Chemours Co CC
- OLIN Corp OLN
- Huntsman CORP HUN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $953.7M | $922.4M | $942.4M | $799.0M |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M |
| Diluted EPS | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 |
| Operating cash flow | $216.6M | $182.0M | $183.8M | $138.5M | $160.5M |
| Free cash flow | — | — | — | $89.5M | $124.4M |
| Total assets | $1.7B | $1.6B | $1.6B | $1.6B | $1.2B |
| Total liabilities | $428.8M | $425.5M | $543.2M | $686.2M | $322.3M |
| Stockholders' equity | $1.3B | $1.1B | $1.1B | $938.3M | $877.0M |
| Cash and investments | $74.6M | $49.5M | $64.4M | $66.6M | $103.2M |
| Total debt | $16.7M | $18.0M | $20.8M | $20.0M | $9.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 23, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 23, 2026 | Oct 23, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 27, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
All 1001 Balchem Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.